Form 4: NHC Senior VP Sells Shares for Tax Obligations
Insider Transaction Report
National Healthcare Corp's Senior VP & CIO, Ben Anderson Flatt, disposed of 403 common shares to cover tax liabilities following a restricted stock vesting event.
Summary
- Ben Anderson Flatt, Senior VP & CIO of National Healthcare Corp (NHC), reported a transaction on January 1, 2026.
- The transaction involved the disposition of 403 shares of NHC Common Stock at a price of $137.09 per share.
- This disposition was to satisfy tax obligations related to the vesting of 1,070 restricted stock units.
- The restricted stock units were originally granted on March 8, 2023, March 5, 2024, and March 5, 2025, with 33 1/3% vesting on January 1, 2026.
- Following this transaction, Mr. Flatt directly beneficially owns 14,117.0547 shares of Common Stock.
- Mr. Flatt also holds options to purchase Common Stock: 7,467 shares at an exercise price of $53.94 (exercisable 03/08/2024, expires 03/08/2028), 12,000 shares at an exercise price of $94.10 (exercisable 03/05/2025, expires 03/05/2029), and 13,500 shares at an exercise price of $90.62 (exercisable 02/24/2026, expires 02/24/2030).
Sentiment
Score: 5
Explanation: The filing reports a routine, pre-planned insider transaction for tax purposes related to restricted stock vesting. It does not indicate any significant positive or negative operational or financial developments for the company.
Positives
- Vesting of 1,070 restricted stock units indicates successful achievement of performance or tenure milestones for the executive.
- The transaction was executed to cover tax liabilities, which is a standard and expected event upon restricted stock vesting.
Negatives
- A reduction of 403 shares in direct beneficial ownership, although for tax purposes.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
This filing is a routine insider transaction report and does not provide information to analyze broader industry trends or competitors.
Stakeholder Impact
- Shareholders: Minimal direct impact as it's a routine, pre-planned tax-related transaction by an insider.
- Employees: No direct impact mentioned.
- Customers: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 03/08/2023 | Original grant date for a portion of restricted stock. |
| 03/05/2024 | Original grant date for a portion of restricted stock and date exercisable for 7,467 stock options. |
| 03/05/2025 | Original grant date for a portion of restricted stock and date exercisable for 12,000 stock options. |
| 01/01/2026 | Date of restricted stock vesting and subsequent share disposition for tax. |
| 01/05/2026 | Signature date of the reporting person on the filing. |
| 02/24/2026 | Date exercisable for 13,500 stock options. |
| 03/08/2028 | Expiration date for 7,467 stock options. |
| 03/05/2029 | Expiration date for 12,000 stock options. |
| 02/24/2030 | Expiration date for 13,500 stock options. |
Keywords
National Healthcare Corp, NHC, insider transaction, Form 4, restricted stock, stock options, executive compensation, beneficial ownership, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.